AI-generated summary
The authors randomized 36 patients with mild to moderate carpal tunnel syndrome to an 830-nm diode laser group or a sham laser group, with treatment over 2 weeks. They report that pain scores were significantly lower in the laser group after treatment and at follow-up, while nerve conduction results showed no significant between-group difference.
- Participants
- 36
- Who or what was studied
- Patients with mild to moderate carpal tunnel syndrome
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract describes a single small placebo-controlled trial with 36 patients, and it does not report the certainty of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 60 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Visual analogue scale, Placebo-controlled, Duty cycle, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.